Estevao Mauricio Bagi

Royal Brompton & Harefield Hospitals Specialist Care

A degree in Nuclear Medicine in 2013 from Escola Superior de Tecnologia da Saúde de Lisboa (ESTeSL), integrada no Instituto Politécnico de Lisboa (IPL), Lisbon, Portugal.

Professional expertise in General Nuclear Medicine, Radiopharmacy, Nuclear Medicine Cardiology; Phases 1 and 2 of Clinical Trials; PET/CT Imaging: General Oncology, Cardiology with Rubidium-82 and Neurology (Dementia).
Currently working as Lead of Rubidium-82 Operations for the Royal Brompton & Harefield Hospitals Specialist Care at 77 Wimpole St, new facility at Harley Street Medical area that opened in June 2016.
Background:
Nuclear Medicine at North Middlesex University Hospital
Imperial College Healthcare NHS Trust: Charing Cross Hospital- Imaging Department.
Ashfordand St. Peter''s Hospitals NHS Trust
Lead of Radiopharmacy trials at Hammersmith Medicines Research Ltd
Senior I of PETCT Imaging Alliance Medical

Seminars and Publications:
EANM 2017 Congress- October 21 – 25, 2017 Vienna, Austria:Oral Presentation
51st BNMS Spring Meeting – Birmingham 20- 22 May 2017:Oral Presentation
BNCS AGM- NHLI in London on Friday 28th April2017: Oral Presentation: Nuclear Medicine Communications. 38:e1-e3, August 2017.

dont miss

Cardiac PET-CT : Rubidium-82 Myocardium Perfusion & 18F-FDG Cardiac Sarcoidosis

Myocardial perfusion imaging with 82Rb PET-CT has gained increased confidence in Europe/UK due to improved diagnostic accuracy and reduced radiation dose compared to SPECT.

18F- FDG PET has significant advantages in assessing disease activity and monitoring treatment response in patients with cardiac sarcoidosis. Combining Rb-82 myocardium perfusion with 18F-FDG will characterise the FDG avid myocardial lesions.

EVEN MORE SEMINARS

  • Andy Rogers: Speaking at the European Neurological Convention

    Andy Rogers
    Nottingham University Hospitals

    Interventional staff dose reduction: Gaining insight through new technology

  • Professor David Maintz: Speaking at the European Neurological Convention

    Professor David Maintz
    University Hospital Cologne, Department of Radiology

    Spectral CT: Dual layer technology helps to increase diagnostic confidence

  • Dr John Buscombe: Speaking at the European Neurological Convention

    Dr John Buscombe
    British Nuclear Medicine Society

    Theranostics in prostate cancer new or false dawn

  • Prof Sam Janes: Speaking at the European Neurological Convention

    Prof Sam Janes
    Delivering CT screening for Lung Cancer in the UK

    Delivering CT screening for Lung Cancer in the UK

  • Laura Allington: Speaking at the European Neurological Convention

    Laura Allington
    University College London Hospitals NHS Foundation Trust

    Operational challenges of planning a new NHS high energy proton service.